PBI63 IMPACT OF TOCILIZUMAB SUBCUTANEOUS INJECTION COMMERCIALIZATION ON PRACTICES IN THE PUBLIC HOSPITALS OF PARIS
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.167
https://www.valueinhealthjournal.com/article/S1098-3015(19)32545-8/fulltext
Section Title :
Section Order :
10118
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32545-8&doi=10.1016/j.jval.2019.09.167